The paediatric liver transplantation program at the Université catholique de Louvain.

Reding, Raymond;Ciccarelli, Olga;Bourdeaux, Christophe;Gras, Jeremie;Otte, Jean-Bernard;et.al.
(2004) Acta Gastro-Enterologica Belgica (Multilingual Edition) — Vol. 67, n° 2, p. 176-178 (2004)

Files

9908.pdf
  • Restricted Access
  • Adobe PDF
  • 3.29 MB

Details

Authors
  • Reding, RaymondUCLouvain
    Author
  • Author
  • Bourdeaux, ChristopheUCLouvain
    Author
  • Gras, JeremieUCLouvain
    Author
  • Buts, Jean-PaulUCLouvain
    Author
  • Carlier, MarianneUCLouvain
    Author
  • Clapuyt, PhilippeUCLouvain
    Author
  • Clément de clety, StéphanUCLouvain
    Author
  • De Kock, MarcUCLouvain
    Author
  • Hermans, DominiqueUCLouvain
    Author
  • Moulin, DidierUCLouvain
    Author
  • Rahier, JacquesUCLouvain
    Author
  • Sempoux, ChristineUCLouvain
    Author
  • Van Obbergh, LucUCLouvain
    Author
  • Veyckemans, FrancisUCLouvain
    Author
  • Lerut, JanUCLouvain
    Author
  • Sokal, EtienneUCLouvain
    Author
  • Otte, Jean-BernardUCLouvain
    Author
Show more
Abstract
The Paediatric Liver Transplant Program at Saint-Luc University Clinics constitutes a substantial single centre experience, including 667 transplantations performed between March 1984 and April 2003, and the history of this program reflects the tremendous progress in this field since twenty years. Liver transplantation in children constitutes a considerable undertaking and its results depend on multiple, intermingled risk factors. An analysis of the respective impact of several surgical and immunological parameters on patient/graft outcome and allograft rejection after paediatric liver transplantation showed a significant learning curve effect as well as the respective impact of pre-transplant diagnosis on survival and of primary immunosuppression on the rejection incidence. The introduction of living related liver transplantation in 1993 not only permitted to provide access to liver replacement in as many as 74% more candidate recipients, but also resulted in better graft survival and reduced retransplantation rate. The results of a recent pilot study suggest that steroid avoidance is not harmful, and could even be beneficial for paediatric liver recipients, particularly regarding growth, and that combining tacrolimus with basiliximab (anti-CD25 chimeric monoclonal antibody) for steroid substitution appears to constitute a safe alternative in this context. The long-term issues represent the main future challenges in the field, including the possibility of a full rehabilitation through immunosuppression withdrawal and tolerance induction, the development of adolescence transplant medicine, and the risk of early atherogenesis in the adulthood.
Affiliations

Citations

Reding, R., Ciccarelli, O., Bourdeaux, C., Gras, J., Evrard, V., Buts, J.-P., Carlier, M., Clapuyt, P., Clément de clety, S., De Kock, M., Hermans, D., Janssen, M., Moulin, D., Rahier, J., Saint-Martin, C., Sempoux, C., Van Obbergh, L., Veyckemans, F., Lerut, J., et al. (2004). The paediatric liver transplantation program at the Université catholique de Louvain. Acta Gastro-Enterologica Belgica (Multilingual Edition), 67(2), 176-178. https://hdl.handle.net/2078.5/209592 (Original work published 2004)